Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 5 months ago Drug news

BinaxNOW Influenza A & B Card 2 diagnostic test and reader get 510(k) clearance from FDA - Alere

Alere announced that its Alere Reader, a diagnostic analyzer that can be used in both point-of-care and laboratory settings, has...

Added 7 months ago Drug news

FDA approves marketing application for Xpert Xpress Flu and Xpert Xpress Flu/RSV for influenza-Cepheid

Cepheid announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market Xpert Xpress Flu...

Added 7 months ago Drug news

Rapivab (peramivir) filed with EMA for influenza in adults 18 years and older- BioCryst Pharma

BioCryst Pharmaceuticals announced that the European Medicines Agency (EMA) has accepted the filing of its Rapivab (peramivir) Marketing Authorization Application...

Search all news articles for Influenza
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Visit Oral Anticoagulation Reversal

Journal articles

Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009–10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals

Rheumatoid arthritis (RA) patients under immunosuppressive therapy are particularly susceptible to infections, mainly of the respiratory tract, thus vaccination may...

Added 3 years ago

A/H5N1 prepandemic influenza vaccine (Vepacel®): a guide to its use.

Vepacel® is a prepandemic influenza vaccine (whole virion, Vero cell-derived, inactivated) containing antigen of H5N1 strain A/Vietnam/1203/2004 and is approved...

Added 4 years ago

A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

The influenza A subtype H5N1 virus is a likely causative agent for the next human influenza pandemic. Pandemic influenza vaccine...

Added 5 years ago

Search all journal articles for Influenza
 

CME

Diabetes care, antivirals for flu and dementia risk: update clinical February 2016

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0
Search all CME for Influenza